Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Innovative Technologies for the Treatment of Pulmonary and Heart Failure to Prolong Human's Life

NCT05090930 is registered in ClinicalTrials.gov with National Research Center for Cardiac Surgery, Kazakhstan as lead sponsor.

NCT NCT05090930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05090930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Innovative Technologies for the Treatment of Pulmonary and Heart Failure to Prolong Human's Life
Lead sponsor
National Research Center for Cardiac Surgery, Kazakhstan
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2021
Completion date
December 1, 2023
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure, cardiac arrest with successful resuscitation, cardiogenic shock, decompensated heart failure, multiple organ failure, pulmonary failure, sepsis, ventricular arrythmia